biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Jun 27, 2016 4:59pm

95 Views

Post# 25002659

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Update

If you are so intelligent and understand everything then why have you been wrong on the price of Bioasis since 2012? May be you are right on science and wrong on the stock? Yet, I can find more pps target posts then science ones!

You're such a dimwit. EVERYONE has gotten the predictions of price wrong. There are waaaaaay too many variables to be anything but lucky on a guess.

You tried a BTI content post to again demonstrate your poor critical thinking skills and lack of understanding of BTI and deals. So now you're back to harassment. Stick with what you know I guess. Truly pathetic.

Bullboard Posts

How one company is disrupting PoC testing